2Grant BF, Hasin DS, Stinson FS, et al.Prevalence, correlates, co-morbidity,and comparative disability of DSM-IV gener- alized anxiety disorder in the USA:results from the National Epidemiologic Survey on Alcohol and Related Conditions [J].Psychol Med,2005,35( 12): 1747-1759.
3Wittchen HU,Zhao S, Kesslwer RC,et al.DSM-III-R gen- eralized anxiety disorder in the National Comorbidity Survey [J ].Arch Gen Psychiatry 1994,51 : 355-364.
3Goldstein AJ,de Beurs E,Chambless DL,Wilson KA(2000)EMDR for panic disorder with agoraphobia:comparison with waiting list and credible attention-placebo control conditions.J Consuit Clin Psychol 68:947-956.
4Davidson JR, DuPont RL, Hedges D, Haskins JT (1999) Efficacy,safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalised anxiety disorder. J Clin Plychiatry 60: 528-535.
5Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum 8, Bell J,Maddock R, Hegel MT, Farfel G (2001a) Effcacy of sertraline in preventing relapse of posttrauma(ic stress disorder:results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 158:1974-1981.
6Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM(2001b) Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 58 485-492.
7Coldstein DJ,Sundell K(1999)A review of the safety of selective serotonin reuptake inhibitors during pregnancy.Hum Psychopharmacol Clin Exp 14:319-324.
